United States Biotechnology & Medical Research

Oruka Therapeutics Inc (ORKA)

Track

Track

Oruka Therapeutics experienced significant insider trading activity recently, with executives offloading over 565,000 dollars in net value. Fifty-three transactions occurred, all involving sales rather than acquisitions. This selling trend follows a disappointing earnings report where the company missed expectations by over twelve percent, despite the stock price remaining relatively stable over the past quarter.
Ticker: ORKA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oruka Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
134.66
Quantity 4,081 -11.7%
Value US$1,499,681
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
245.44
Quantity 13,742 -49.4%
Value US$1,527,745
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
275.83
Quantity 20,058 +30.3%
Value US$2,954,665
0.8
LAWRENCE KLEIN Director; Officer Executive Director
Transaction date
Proposed sale
Price
83.29
Quantity 1,000
Value US$100,000
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
95.75
Quantity 1,000 -3.6%
Value US$100,000
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
95.31
Quantity 1,000 -8.2%
Value US$100,000
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
94.44
Quantity 1,000 -1.8%
Value US$100,000
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
93.32
Quantity 1,000 -10.3%
Value US$100,000
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
92.37
Quantity 1,000 -7.3%
Value US$100,000
0.8
Arjun Agarwal Officer Officer
Transaction date
Proposed sale
Price
94.96
Quantity 1,000
Value US$100,000
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Sale
Price
95.71
Quantity 1,000 -2.9%
Value US$100,000
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
94.22
Quantity 1,000 -0.3%
Value US$100,000
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
92.99
Quantity 1,000 -4.0%
Value US$100,000
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
92.03
Quantity 1,000 -8.4%
Value US$100,000
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
91.10
Quantity 1,000 -6.0%
Value US$100,000
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Sale
Price
95.71
Quantity 1,000 -0.3%
Value US$100,000
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Sale
Price
95.71
Quantity 1,000 -3.3%
Value US$100,000
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Sale
Price
95.71
Quantity 1,000 -3.7%
Value US$100,000
0.8
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Sale
Price
95.71
Quantity 1,000 -0.4%
Value US$100,000
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
94.02
Quantity 1,000 -1.3%
Value US$100,000
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
93.26
Quantity 1,000 -12.5%
Value US$100,000
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
92.41
Quantity 1,000 -18.6%
Value US$100,000
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
91.11
Quantity 1,000 -12.1%
Value US$100,000
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
92.44
Quantity 4,800 -0.5%
Value US$443,691
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
91.90
Quantity 63,596 -6.4%
Value US$5,844,237
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
90.79
Quantity 6,604 -0.7%
Value US$599,556
0.8
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
92.01
Quantity 4,000 -1.7%
Value US$368,054
0.8
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
91.05
Quantity 1,000 -0.4%
Value US$91,048
0.8
LAURA SANDLER Officer Officer
Transaction date
Proposed sale
Price
92.62
Quantity 5,000
Value US$463,100
0.8
LAWRENCE KLEIN Director; Officer Executive Director
Transaction date
Proposed sale
Price
92.62
Quantity 75,000
Value US$6,946,500
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
112.56
Quantity 2,480 -7.0%
Value US$279,154
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
112.01
Quantity 3,320 -8.6%
Value US$371,886
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
110.52
Quantity 300 -0.8%
Value US$33,155
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
109.65
Quantity 900 -2.3%
Value US$98,687
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
111.14
Quantity 3,847 -11.0%
Value US$427,547
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
110.00
Quantity 9,193 -20.9%
Value US$1,011,266
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
109.11
Quantity 10,200 -18.8%
Value US$1,112,954
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
107.97
Quantity 14,696 -21.3%
Value US$1,586,779
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
107.14
Quantity 10,434 -13.1%
Value US$1,117,901
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
106.05
Quantity 3,630 -4.4%
Value US$384,963
0.8
PAUL QUINLAN Officer Officer
Transaction date
Proposed sale
Price
108.12
Quantity 71,000
Value US$7,676,520
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
108.46
Quantity 2,358 -13.3%
Value US$255,755
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
107.71
Quantity 2,142 -10.8%
Value US$230,723
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
106.63
Quantity 1,268 -6.0%
Value US$135,201
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
105.57
Quantity 2,132 -9.2%
Value US$225,079
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
104.67
Quantity 2,100 -8.3%
Value US$219,814
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
87.25
Quantity 300 -0.9%
Value US$26,176
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
86.68
Quantity 3,803 -10.3%
Value US$329,630
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
85.86
Quantity 2,497 -6.4%
Value US$214,385
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
84.37
Quantity 400 -1.0%
Value US$33,746
0.8
JOANA GONCALVES Officer Officer
Transaction date
Proposed sale
Price
87.47
Quantity 21,000
Value US$1,836,870
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
85.63
Quantity 300 -1.9%
Value US$25,690
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
84.90
Quantity 5,656 -26.6%
Value US$480,201
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
84.26
Quantity 3,743 -15.0%
Value US$315,369
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
83.07
Quantity 300 -1.2%
Value US$24,920
0.8
Arjun Agarwal Officer Officer
Transaction date
Proposed sale
Price
86.79
Quantity 28,588
Value US$2,481,153
3.3
Fairmount Healthcare Fund II L.P. Director, 10% Stockholder Non-Executive Director Large shareholder
Transaction date
Proposed sale
Price
84.43
Quantity 3,553,410
Value US$300,014,406
3.3
Fairmount Funds Management LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
84.43
Quantity 3,553,410 -75.8%
Value US$300,014,406
0.8
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
95.47
Quantity 500 -0.2%
Value US$47,736
0.8
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
94.75
Quantity 2,263 -0.9%
Value US$214,410
0.8
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
93.85
Quantity 2,237 -0.9%
Value US$209,933
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
82.15
Quantity 699 -4.4%
Value US$57,419
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
82.15
Quantity 699 -4.4%
Value US$57,419
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
80.01
Quantity 888 -5.3%
Value US$71,049
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
80.01
Quantity 888 -5.3%
Value US$71,049
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Sale
Price
69.69
Quantity 395 -2.3%
Value US$27,528
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Sale
Price
69.69
Quantity 947 -2.8%
Value US$65,996
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
70.62
Quantity 300 -0.9%
Value US$21,187
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
69.42
Quantity 5,064 -13.0%
Value US$351,547
0.8
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
68.38
Quantity 1,636 -4.0%
Value US$111,876
0.8
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Sale
Price
69.69
Quantity 1,729 -0.2%
Value US$120,494
0.8
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Sale
Price
69.69
Quantity 600 -0.3%
Value US$41,814
0.8
Quinlan Paul T General Counsel Officer
Transaction date
Sale
Price
69.69
Quantity 733 -2.3%
Value US$51,083
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
70.34
Quantity 3,260 -15.9%
Value US$229,306
0.8
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
69.85
Quantity 4,340 -17.4%
Value US$303,154
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-01 PlS Planned sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
4,081 -11.7%
134.66
US$1,499,681 		4,081 -11.7% 134.66 US$1,499,681
2026-10-02 2026-10-01 PlS Planned sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
13,742 -49.4%
245.44
US$1,527,745 		13,742 -49.4% 245.44 US$1,527,745
2026-10-02 2026-10-01 PlS Planned sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
20,058 +30.3%
275.83
US$2,954,665 		20,058 +30.3% 275.83 US$2,954,665
2026-10-01 2026-10-01 PrS Proposed sale
0.8
LAWRENCE KLEIN

Director; Officer

Executive Director
1,000
83.29
US$100,000 		1,000 83.29 US$100,000
2026-09-21 2026-09-21 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -3.6%
95.75
US$100,000 		1,000 -3.6% 95.75 US$100,000
2026-09-21 2026-09-21 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
1,000 -8.2%
95.31
US$100,000 		1,000 -8.2% 95.31 US$100,000
2026-09-21 2026-09-21 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
1,000 -1.8%
94.44
US$100,000 		1,000 -1.8% 94.44 US$100,000
2026-09-21 2026-09-21 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
1,000 -10.3%
93.32
US$100,000 		1,000 -10.3% 93.32 US$100,000
2026-09-21 2026-09-21 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
1,000 -7.3%
92.37
US$100,000 		1,000 -7.3% 92.37 US$100,000
2026-09-21 2026-09-21 PrS Proposed sale
0.8
Arjun Agarwal

Officer

Officer
1,000
94.96
US$100,000 		1,000 94.96 US$100,000
2026-09-15 2026-09-15 S Sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
1,000 -2.9%
95.71
US$100,000 		1,000 -2.9% 95.71 US$100,000
2026-09-15 2026-09-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
1,000 -0.3%
94.22
US$100,000 		1,000 -0.3% 94.22 US$100,000
2026-09-15 2026-09-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
1,000 -4.0%
92.99
US$100,000 		1,000 -4.0% 92.99 US$100,000
2026-09-15 2026-09-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
1,000 -8.4%
92.03
US$100,000 		1,000 -8.4% 92.03 US$100,000
2026-09-15 2026-09-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
1,000 -6.0%
91.10
US$100,000 		1,000 -6.0% 91.10 US$100,000
2026-09-15 2026-09-15 S Sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
1,000 -0.3%
95.71
US$100,000 		1,000 -0.3% 95.71 US$100,000
2026-09-15 2026-09-15 S Sale
0.8
Quinlan Paul T

General Counsel

Officer
1,000 -3.3%
95.71
US$100,000 		1,000 -3.3% 95.71 US$100,000
2026-09-15 2026-09-15 S Sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -3.7%
95.71
US$100,000 		1,000 -3.7% 95.71 US$100,000
2026-09-15 2026-09-15 S Sale
0.8
Sandler Laura Lee

Chief Operating Officer

Officer
1,000 -0.4%
95.71
US$100,000 		1,000 -0.4% 95.71 US$100,000
2026-09-15 2026-09-11 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -1.3%
94.02
US$100,000 		1,000 -1.3% 94.02 US$100,000
2026-09-15 2026-09-11 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -12.5%
93.26
US$100,000 		1,000 -12.5% 93.26 US$100,000
2026-09-15 2026-09-11 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -18.6%
92.41
US$100,000 		1,000 -18.6% 92.41 US$100,000
2026-09-15 2026-09-11 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
1,000 -12.1%
91.11
US$100,000 		1,000 -12.1% 91.11 US$100,000
2026-09-01 2026-09-01 PlS Planned sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
4,800 -0.5%
92.44
US$443,691 		4,800 -0.5% 92.44 US$443,691
2026-09-01 2026-09-01 PlS Planned sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
63,596 -6.4%
91.90
US$5,844,237 		63,596 -6.4% 91.90 US$5,844,237
2026-09-01 2026-09-01 PlS Planned sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
6,604 -0.7%
90.79
US$599,556 		6,604 -0.7% 90.79 US$599,556
2026-09-01 2026-09-01 PlS Planned sale
0.8
Sandler Laura Lee

Chief Operating Officer

Officer
4,000 -1.7%
92.01
US$368,054 		4,000 -1.7% 92.01 US$368,054
2026-09-01 2026-09-01 PlS Planned sale
0.8
Sandler Laura Lee

Chief Operating Officer

Officer
1,000 -0.4%
91.05
US$91,048 		1,000 -0.4% 91.05 US$91,048
2026-09-01 2026-09-01 PrS Proposed sale
0.8
LAURA SANDLER

Officer

Officer
5,000
92.62
US$463,100 		5,000 92.62 US$463,100
2026-09-01 2026-09-01 PrS Proposed sale
0.8
LAWRENCE KLEIN

Director; Officer

Executive Director
75,000
92.62
US$6,946,500 		75,000 92.62 US$6,946,500
2026-08-17 2026-08-17 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
2,480 -7.0%
112.56
US$279,154 		2,480 -7.0% 112.56 US$279,154
2026-08-17 2026-08-17 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
3,320 -8.6%
112.01
US$371,886 		3,320 -8.6% 112.01 US$371,886
2026-08-17 2026-08-17 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
300 -0.8%
110.52
US$33,155 		300 -0.8% 110.52 US$33,155
2026-08-17 2026-08-17 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
900 -2.3%
109.65
US$98,687 		900 -2.3% 109.65 US$98,687
2026-08-14 2026-08-14 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
3,847 -11.0%
111.14
US$427,547 		3,847 -11.0% 111.14 US$427,547
2026-08-14 2026-08-14 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
9,193 -20.9%
110.00
US$1,011,266 		9,193 -20.9% 110.00 US$1,011,266
2026-08-14 2026-08-14 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
10,200 -18.8%
109.11
US$1,112,954 		10,200 -18.8% 109.11 US$1,112,954
2026-08-14 2026-08-14 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
14,696 -21.3%
107.97
US$1,586,779 		14,696 -21.3% 107.97 US$1,586,779
2026-08-14 2026-08-14 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
10,434 -13.1%
107.14
US$1,117,901 		10,434 -13.1% 107.14 US$1,117,901
2026-08-14 2026-08-14 PlS Planned sale
0.8
Quinlan Paul T

General Counsel

Officer
3,630 -4.4%
106.05
US$384,963 		3,630 -4.4% 106.05 US$384,963
2026-08-14 2026-08-14 PrS Proposed sale
0.8
PAUL QUINLAN

Officer

Officer
71,000
108.12
US$7,676,520 		71,000 108.12 US$7,676,520
2026-08-14 2026-08-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
2,358 -13.3%
108.46
US$255,755 		2,358 -13.3% 108.46 US$255,755
2026-08-14 2026-08-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
2,142 -10.8%
107.71
US$230,723 		2,142 -10.8% 107.71 US$230,723
2026-08-14 2026-08-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
1,268 -6.0%
106.63
US$135,201 		1,268 -6.0% 106.63 US$135,201
2026-08-14 2026-08-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
2,132 -9.2%
105.57
US$225,079 		2,132 -9.2% 105.57 US$225,079
2026-08-14 2026-08-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
2,100 -8.3%
104.67
US$219,814 		2,100 -8.3% 104.67 US$219,814
2026-07-15 2026-07-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
300 -0.9%
87.25
US$26,176 		300 -0.9% 87.25 US$26,176
2026-07-15 2026-07-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
3,803 -10.3%
86.68
US$329,630 		3,803 -10.3% 86.68 US$329,630
2026-07-15 2026-07-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
2,497 -6.4%
85.86
US$214,385 		2,497 -6.4% 85.86 US$214,385
2026-07-15 2026-07-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
400 -1.0%
84.37
US$33,746 		400 -1.0% 84.37 US$33,746
2026-07-15 2026-07-15 PrS Proposed sale
0.8
JOANA GONCALVES

Officer

Officer
21,000
87.47
US$1,836,870 		21,000 87.47 US$1,836,870
2026-07-13 2026-07-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
300 -1.9%
85.63
US$25,690 		300 -1.9% 85.63 US$25,690
2026-07-13 2026-07-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
5,656 -26.6%
84.90
US$480,201 		5,656 -26.6% 84.90 US$480,201
2026-07-13 2026-07-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
3,743 -15.0%
84.26
US$315,369 		3,743 -15.0% 84.26 US$315,369
2026-07-13 2026-07-13 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
300 -1.2%
83.07
US$24,920 		300 -1.2% 83.07 US$24,920
2026-07-13 2026-07-13 PrS Proposed sale
0.8
Arjun Agarwal

Officer

Officer
28,588
86.79
US$2,481,153 		28,588 86.79 US$2,481,153
2026-07-01 2026-07-01 PrS Proposed sale
3.3
Fairmount Healthcare Fund II L.P.

Director, 10% Stockholder

Non-Executive Director Large shareholder
3,553,410
84.43
US$300,014,406 		3,553,410 84.43 US$300,014,406
2026-07-01 2026-07-01 S Sale
3.3
Fairmount Funds Management LLC
Non-Executive Director Large shareholder
3,553,410 -75.8%
84.43
US$300,014,406 		3,553,410 -75.8% 84.43 US$300,014,406
2026-07-01 2026-07-01 PlS Planned sale
0.8
Sandler Laura Lee

Chief Operating Officer

Officer
500 -0.2%
95.47
US$47,736 		500 -0.2% 95.47 US$47,736
2026-07-01 2026-07-01 PlS Planned sale
0.8
Sandler Laura Lee

Chief Operating Officer

Officer
2,263 -0.9%
94.75
US$214,410 		2,263 -0.9% 94.75 US$214,410
2026-07-01 2026-07-01 PlS Planned sale
0.8
Sandler Laura Lee

Chief Operating Officer

Officer
2,237 -0.9%
93.85
US$209,933 		2,237 -0.9% 93.85 US$209,933
2026-06-22 2026-06-22 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
699 -4.4%
82.15
US$57,419 		699 -4.4% 82.15 US$57,419
2026-06-22 2026-06-22 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
699 -4.4%
82.15
US$57,419 		699 -4.4% 82.15 US$57,419
2026-06-22 2026-06-22 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
888 -5.3%
80.01
US$71,049 		888 -5.3% 80.01 US$71,049
2026-06-22 2026-06-22 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
888 -5.3%
80.01
US$71,049 		888 -5.3% 80.01 US$71,049
2026-06-15 2026-06-15 S Sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
395 -2.3%
69.69
US$27,528 		395 -2.3% 69.69 US$27,528
2026-06-15 2026-06-15 S Sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
947 -2.8%
69.69
US$65,996 		947 -2.8% 69.69 US$65,996
2026-06-15 2026-06-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
300 -0.9%
70.62
US$21,187 		300 -0.9% 70.62 US$21,187
2026-06-15 2026-06-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
5,064 -13.0%
69.42
US$351,547 		5,064 -13.0% 69.42 US$351,547
2026-06-15 2026-06-15 PlS Planned sale
0.8
Goncalves Joana

Chief Medical Officer

Officer
1,636 -4.0%
68.38
US$111,876 		1,636 -4.0% 68.38 US$111,876
2026-06-15 2026-06-15 S Sale
0.8
Klein Lawrence Otto

Chief Executive Officer

Executive Director
1,729 -0.2%
69.69
US$120,494 		1,729 -0.2% 69.69 US$120,494
2026-06-15 2026-06-15 S Sale
0.8
Sandler Laura Lee

Chief Operating Officer

Officer
600 -0.3%
69.69
US$41,814 		600 -0.3% 69.69 US$41,814
2026-06-15 2026-06-15 S Sale
0.8
Quinlan Paul T

General Counsel

Officer
733 -2.3%
69.69
US$51,083 		733 -2.3% 69.69 US$51,083
2026-06-15 2026-06-12 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
3,260 -15.9%
70.34
US$229,306 		3,260 -15.9% 70.34 US$229,306
2026-06-15 2026-06-12 PlS Planned sale
0.8
Agarwal Arjun

Senior Vice President, Finance

Officer
4,340 -17.4%
69.85
US$303,154 		4,340 -17.4% 69.85 US$303,154
Explore more

More insider trading research around Oruka Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America